BIOX — Bioceres Crop Solutions Income Statement
0.000.00%
Last trade - 00:00- $215.07m
- $485.55m
- $464.83m
Annual income statement for Bioceres Crop Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 172 | 207 | 328 | 415 | 465 |
| Cost of Revenue | |||||
| Gross Profit | 78.8 | 88.1 | 120 | 180 | 187 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 133 | 168 | 289 | 361 | 420 |
| Operating Profit | 39.1 | 38.4 | 39.9 | 54.2 | 44.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 6.44 | 10.5 | 14.1 | 19.1 | 10 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 4.24 | -3.82 | -3.91 | 20.2 | 6.26 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | 3.36 | -6.87 | -7.2 | 18.8 | 3.24 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 3.36 | -6.87 | -7.2 | 18.8 | 3.24 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.079 | -0.222 | -0.268 | 0.291 | 0.052 |